Literature DB >> 11001093

An MCD spectroscopic study of the molybdenum active site in sulfite oxidase: insight into the role of coordinated cysteine.

M E Helton1, A Pacheco, J McMaster, J H Enemark, M L Kirk.   

Abstract

Temperature-dependent magnetic circular dichroism (MCD) spectroscopy has been used for the first time to probe the electronic structure of the Mo active site in sulfite oxidase (SO). The enzyme was poised in the catalytically relevant [Mo(V):Fe(II)] state by anaerobic reduction of the enzyme with the natural substrate, sulfite, in the absence of the physiological oxidant cytochrome c. The [Mo(V):Fe(II)] state is of particular importance, as it is proposed to be a catalytic intermediate in the oxidative half reaction, where SO is reoxidized to the resting [Mo(VI):Fe(III)] state by two sequential one-electron transfers to cytochrome c. The MCD spectrum of the enzyme shows no charge transfer transitions below approximately 17000 cm(-1). This has been interpreted to result from (1) a severe reduction in ene-1,2-dithiolate sulfur in-plane and out-of-plane p orbital mixing, (2) a decrease in the dithiolate sulfur out-of-plane p-Mo d(xy) orbital overlap, and (3) an orthogonal orientation between the vertical cysteine sulfur p (perpendicular to the Mo-Scys sigma-bond) and Mo d(xy) orbitals. The spectroscopically determined cysteine sulfur p-Mo d(xy) bonding scheme in the [Mo(V):Fe(II)] state is consistent with the crystallographically determined O-Mo-Scys-C dihedral angle of approximately 90 degrees and precludes a covalent interaction between the vertical cysteine sulfur p orbital and Mo d(xy), effectively decoupling the cysteine from an effective through-bond electron transfer pathway. We have tentatively assigned a 22250 cm(-1) positive C-term feature in the MCD as the cysteine S(sigma)-->Mo d(xy) charge transfer that becomes allowed by a combination of configuration interaction and low-symmetry; however, the orbital overlap is anticipated to be quite small due to the near orthogonality of these orbitals. Therefore, we propose that the primary role of the coordinated cysteine is to decrease the effective nuclear charge on Mo by charge donation to the metal, statically poising the active site at more negative reduction potentials during electron transfer (ET) regeneration. Finally, the results of this study are consistent with the pyranopterin ene-1,2-dithiolate acting to couple the Mo site into efficient superexchange pathways for ET regeneration following oxygen atom transfer to the substrate.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11001093     DOI: 10.1016/s0162-0134(00)00082-9

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  6 in total

1.  Synthesis, characterization, and spectroscopy of model molybdopterin complexes.

Authors:  Sharon J Nieter Burgmayer; Mary Kim; Rebecca Petit; Amy Rothkopf; Alison Kim; Shadia BelHamdounia; Ying Hou; Arpad Somogyi; Diana Habel-Rodriguez; Antonio Williams; Martin L Kirk
Journal:  J Inorg Biochem       Date:  2007-07-21       Impact factor: 4.155

Review 2.  Sulfite oxidizing enzymes.

Authors:  Changjian Feng; Gordon Tollin; John H Enemark
Journal:  Biochim Biophys Acta       Date:  2007-03-20

3.  Spectroscopic characterization of YedY: the role of sulfur coordination in a Mo(V) sulfite oxidase family enzyme form.

Authors:  Jing Yang; Richard Rothery; Joseph Sempombe; Joel H Weiner; Martin L Kirk
Journal:  J Am Chem Soc       Date:  2009-11-04       Impact factor: 15.419

4.  Molybdenum and Tungsten Cofactors and the Reactions They Catalyze.

Authors:  Martin L Kirk; Khadanand Kc
Journal:  Met Ions Life Sci       Date:  2020-03-23

Review 5.  Spectroscopic Studies of Mononuclear Molybdenum Enzyme Centers.

Authors:  Martin L Kirk; Russ Hille
Journal:  Molecules       Date:  2022-07-27       Impact factor: 4.927

6.  Metal-Dithiolene Bonding Contributions to Pyranopterin Molybdenum Enzyme Reactivity.

Authors:  Jing Yang; John H Enemark; Martin L Kirk
Journal:  Inorganics (Basel)       Date:  2020-03-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.